USPTO Issues Notice of Allowance for IRLAB Drug Candidate Patent
The U.S. Patent and Trademark Office issued a notice of allowance for a patent covering IRLAB’s drug candidate IRL1117.
The U.S. Patent and Trademark Office issued a notice of allowance for a patent covering IRLAB’s drug candidate IRL1117.